Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIV-711 in Knee Joint Osteoarthritis
NCT02705625Phase 2Completed
- Sponsor
- Medivir
- Start
- Jan 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of MIV-711 in osteoarthritis (OA), sponsored by Medivir. Started Jan 2016; status: completed.
02
Drugs
MIV-711
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02705625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705625.